Treatment for Patient on BiPAP During Acute Exacerbation
Continue BiPAP as the primary ventilatory support while simultaneously administering short-acting bronchodilators, systemic corticosteroids, and antibiotics (when indicated) for the acute exacerbation. 1
Core Treatment Algorithm
1. Maintain Non-Invasive Ventilation (NIV/BiPAP)
BiPAP should remain the first-line ventilatory support for acute respiratory failure in COPD exacerbations 1, 2. The evidence strongly supports that NIV decreases mortality (RR 0.63) and reduces intubation needs (RR 0.41) in patients with acute hypercapnic respiratory failure 2.
Key BiPAP parameters to monitor:
- Continue when pH ≤7.35, PaCO2 >45 mmHg, respiratory rate >20-24 breaths/min 2
- There is no lower pH limit that automatically excludes BiPAP trial, though pH <7.26 carries higher failure risk 2
- Reassess arterial blood gases within 60 minutes of any change 3
2. Bronchodilator Therapy
Administer nebulized bronchodilators immediately and continue every 4-6 hours 1, 3:
- For moderate exacerbations: Either salbutamol 2.5-5 mg OR ipratropium bromide 0.25-0.5 mg 3
- For severe exacerbations or poor response: Combine both agents 3
Critical pitfall: If the patient has elevated PaCO2 or respiratory acidosis, nebulizers must be driven by compressed air (not oxygen), with supplemental oxygen delivered separately via nasal prongs at 1-2 L/min 3
3. Systemic Corticosteroids
Administer oral prednisolone 30 mg daily for 7-14 days 1, 3. Systemic corticosteroids improve lung function, oxygenation, shorten recovery time, and reduce hospitalization duration 1. If oral route is not possible, use IV hydrocortisone 100 mg 3.
4. Antibiotics (When Indicated)
Prescribe antibiotics if the patient has ≥2 of the following 3:
- Increased breathlessness
- Increased sputum volume
- Development of purulent sputum
First-line: amoxicillin or tetracycline 3. For severe exacerbations or poor response, use broad-spectrum cephalosporin or newer macrolides 3.
5. Oxygen Therapy
Target PaO2 ≥6.6 kPa (≥50 mmHg) without dropping pH below 7.26 3. Start with FiO2 ≤28% via Venturi mask or ≤2 L/min via nasal cannula until arterial blood gases are known 3. Recheck blood gases within 60 minutes of starting oxygen and after any concentration changes 3.
When to Escalate from BiPAP
Consider intubation if:
- pH continues falling despite BiPAP and medical therapy
- Patient becomes confused, exhausted, or develops coma (though coma alone is not an absolute contraindication to BiPAP trial) 2
- Respiratory arrest or apneic episodes occur 2
- Hemodynamic instability (HR <60 bpm, systolic BP <80 mmHg) 2
- Large volume of secretions that cannot be managed 3
Important nuance: A trial of BiPAP is recommended even for patients who might otherwise require immediate intubation, unless the patient is immediately deteriorating 2. This approach reduces nosocomial pneumonia (OR 0.26), shortens ICU stay, and decreases complications compared to immediate intubation 2.
Monitoring Parameters
Reassess within 2 hours of initiating treatment:
- If pH improves after 45 minutes of BiPAP with optimal settings, success is likely 4
- If pH remains <7.28 after 45 minutes, failure risk is high 4
- High SOFA scores at admission predict BiPAP failure 5
Medications to Avoid
Do NOT use methylxanthines (aminophylline/theophylline) due to side effects and lack of proven benefit 1.
Transition Strategy
Once improving clinically (typically 24-48 hours), transition from nebulized bronchodilators to metered-dose inhalers 3. Initiate long-acting bronchodilators before hospital discharge 1. Discontinue corticosteroids after 7-14 days unless there is documented benefit in stable state 3.